114 related articles for article (PubMed ID: 24556942)
1. Limited significance of activated Akt-mammalian target of rapamycin signaling pathway in prostate cancer progression.
Ko YH; Miyake H; Behnsawy HM; Cheon J; Fujisawa M
Urol Int; 2014; 93(2):146-51. PubMed ID: 24556942
[TBL] [Abstract][Full Text] [Related]
2. Activation of the mammalian target of rapamycin signalling pathway in prostate cancer and its association with patient clinicopathological characteristics.
Dai B; Kong YY; Ye DW; Ma CG; Zhou X; Yao XD
BJU Int; 2009 Oct; 104(7):1009-16. PubMed ID: 19389013
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical examination of the mTORC1 pathway in high grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinomas (PCa): a tissue microarray study (TMA).
Evren S; Dermen A; Lockwood G; Fleshner N; Sweet J
Prostate; 2010 Sep; 70(13):1429-36. PubMed ID: 20687216
[TBL] [Abstract][Full Text] [Related]
4. MAGI-2 in prostate cancer: an immunohistochemical study.
Goldstein J; Borowsky AD; Goyal R; Roland JT; Arnold SA; Gellert LL; Clark PE; Hameed O; Giannico GA
Hum Pathol; 2016 Jun; 52():83-91. PubMed ID: 26980016
[TBL] [Abstract][Full Text] [Related]
5. Multiple cores of high grade prostatic intraepithelial neoplasia and any core of atypia on first biopsy are significant predictor for cancer detection at a repeat biopsy.
Kim TS; Ko KJ; Shin SJ; Ryoo HS; Song W; Sung HH; Han DH; Jeong BC; Seo SI; Jeon SS; Lee KS; Lee SW; Lee HM; Choi HY; Jeon HG
Korean J Urol; 2015 Dec; 56(12):796-802. PubMed ID: 26682019
[TBL] [Abstract][Full Text] [Related]
6. Concomitant high-grade prostatic intraepithelial neoplasia is associated with good prognosis factors and oncologic outcome after radical prostatectomy.
Ingels A; Ploussard G; Allory Y; Abbou C; de la Taille A; Salomon L
Urol Int; 2014; 92(3):264-9. PubMed ID: 23919964
[TBL] [Abstract][Full Text] [Related]
7. Morphoproteomics demonstrates activation of mammalian target of rapamycin pathway in papillary thyroid carcinomas with nuclear translocation of MTOR in aggressive histological variants.
Liu J; Brown RE
Mod Pathol; 2011 Dec; 24(12):1553-9. PubMed ID: 21822208
[TBL] [Abstract][Full Text] [Related]
8. Expression of mTOR signaling pathway markers in prostate cancer progression.
Kremer CL; Klein RR; Mendelson J; Browne W; Samadzedeh LK; Vanpatten K; Highstrom L; Pestano GA; Nagle RB
Prostate; 2006 Aug; 66(11):1203-12. PubMed ID: 16652388
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of MKK4, MKK6 and MKK7 during prostate cancer progression: an important role for SAPK signalling in prostatic neoplasia.
Lotan TL; Lyon M; Huo D; Taxy JB; Brendler C; Foster BA; Stadler W; Rinker-Schaeffer CW
J Pathol; 2007 Aug; 212(4):386-94. PubMed ID: 17577251
[TBL] [Abstract][Full Text] [Related]
10. The role of high-grade prostatic intraepithelial neoplasia for biochemical relapse of prostate carcinoma after radical prostatectomy.
Auskalnis S; Milonas D; Jievaltas M; Vaiciūnas K; Mickevicius A; Gudinaviciene I
Medicina (Kaunas); 2010; 46(9):604-10. PubMed ID: 21252594
[TBL] [Abstract][Full Text] [Related]
11. MYC cooperates with AKT in prostate tumorigenesis and alters sensitivity to mTOR inhibitors.
Clegg NJ; Couto SS; Wongvipat J; Hieronymus H; Carver BS; Taylor BS; Ellwood-Yen K; Gerald WL; Sander C; Sawyers CL
PLoS One; 2011 Mar; 6(3):e17449. PubMed ID: 21394210
[TBL] [Abstract][Full Text] [Related]
12. ERG and PTEN status of isolated high-grade PIN occurring in cystoprostatectomy specimens without invasive prostatic adenocarcinoma.
Morais CL; Guedes LB; Hicks J; Baras AS; De Marzo AM; Lotan TL
Hum Pathol; 2016 Sep; 55():117-25. PubMed ID: 27189342
[TBL] [Abstract][Full Text] [Related]
13. Initial high-grade prostatic intraepithelial neoplasia with carcinoma on subsequent prostate needle biopsy: findings at radical prostatectomy.
Al-Hussain TO; Epstein JI
Am J Surg Pathol; 2011 Aug; 35(8):1165-7. PubMed ID: 21716083
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneous clinicopathological features of intraductal carcinoma of the prostate: a comparison between "precursor-like" and "regular type" lesions.
Miyai K; Divatia MK; Shen SS; Miles BJ; Ayala AG; Ro JY
Int J Clin Exp Pathol; 2014; 7(5):2518-26. PubMed ID: 24966964
[TBL] [Abstract][Full Text] [Related]
15. Increase of AKT/PKB expression correlates with gleason pattern in human prostate cancer.
Liao Y; Grobholz R; Abel U; Trojan L; Michel MS; Angel P; Mayer D
Int J Cancer; 2003 Nov; 107(4):676-80. PubMed ID: 14520710
[TBL] [Abstract][Full Text] [Related]
16. The presence of high-grade prostatic intraepithelial neoplasia or atypia on prostate biopsy does not adversely affect prostatectomy outcomes for patients otherwise eligible for active surveillance.
Pietzak EJ; Kabarriti AE; Mucksavage P; Bavaria T; Van Arsdalen K; Malkowicz SB; Wein AJ; Guzzo TJ
Urology; 2014 Dec; 84(6):1442-7. PubMed ID: 25288572
[TBL] [Abstract][Full Text] [Related]
17. Monofocal and plurifocal high-grade prostatic intraepithelial neoplasia on extended prostate biopsies: factors predicting cancer detection on extended repeat biopsy.
Roscigno M; Scattoni V; Freschi M; Raber M; Colombo R; Bertini R; Montorsi F; Rigatti P
Urology; 2004 Jun; 63(6):1105-10. PubMed ID: 15183961
[TBL] [Abstract][Full Text] [Related]
18. Expression of phosphorylated-mTOR during the development of prostate cancer.
Sutherland SI; Pe Benito R; Henshall SM; Horvath LG; Kench JG
Prostate; 2014 Sep; 74(12):1231-9. PubMed ID: 25043667
[TBL] [Abstract][Full Text] [Related]
19. Effect of high-grade prostatic intraepithelial neoplasia on total and percent free serum prostatic-specific antigen.
Morote J; Raventós CX; Encabo G; López M; de Torres IM
Eur Urol; 2000 Apr; 37(4):456-9. PubMed ID: 10765077
[TBL] [Abstract][Full Text] [Related]
20. Histopathological features of intra-ductal carcinoma of prostatic and high grade prostatic intraepithelialneoplasia and correlation with PTEN and P63.
Torabi-Nezhad S; Malekmakan L; Mashayekhi M; Daneshian A
Prostate; 2016 Mar; 76(4):394-401. PubMed ID: 26643011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
